Greek Yew Tree Holds Key to Cancer Drug Development, Study Finds

FILE PHOTO. Courtesy of Pacific Northwest National Laboratory / Flickr / CC BY-NC-SA 2.0

A caller survey by the Aristotle University of Thessaloniki (AUTh) highlights the familial diverseness and medicinal value of the European Yew (Taxus baccata), a uncommon histrion recovered successful the Greek mountains with large imaginable for anti-cancer drug development.

The research, conducted by the Laboratory of Forest Genetics nether the coordination of Professor Filippos Aravanopoulos, identified cardinal populations of the yew successful Greece that service arsenic invaluable earthy sources of taxanes. These compounds are the superior ingredients successful wide utilized chemotherapy drugs specified arsenic Paclitaxel (Taxol).

Key probe findings

• Regional Diversity: The survey examined 3 chiseled populations successful Northern Greece—Mount Cholomontas, Mount Olympus, and Mount Vourinos.
• High Potency: Researchers recovered important saltation successful taxane accumulation betwixt regions. Specifically, Mount Olympus showed the highest concentrations of 10-deacetylbaccatin III, a important precursor for the semi-synthetic accumulation of Paclitaxel.
• Genetic Resilience: Beyond chemic potency, the survey revealed precocious familial diverseness and DNA methylation patterns that suggest these trees person a beardown capableness to accommodate to terrible clime change.

The findings pave the mode for familial betterment programs aimed astatine cultivating yew trees with precocious taxane yields without compromising familial integrity. Furthermore, the survey underscores the urgent request to support these rare, fragmented populations done enhanced conservation presumption and systematic monitoring.

Related: A Living Witness to History: The Millennium-Old Tree of Lake Kerkini, Greece